List of Contents

Negative Pressure Wound Therapy Market Size, Share, and Trends 2024 to 2033

Negative Pressure Wound Therapy Market (By Product Type: Conventional NPWT Devices, Single-use NPWT Devices, NPWT Accessories; By Wound Type: Chronic Wounds, Pressure Ulcer, Acute Wounds; By End-use Type: Hospital, Specialty Clinics, Home Healthcare, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

  • Last Updated : May 2024
  • Report Code : 4239
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Negative Pressure Wound Therapy Market 

5.1. COVID-19 Landscape: Negative Pressure Wound Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Negative Pressure Wound Therapy Market, By Product Type

8.1. Negative Pressure Wound Therapy Market Revenue and Volume, by Product Type, 2024-2033

8.1.1 Conventional NPWT Devices

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Single-use NPWT Devices

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. NPWT Accessories

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. Global Negative Pressure Wound Therapy Market, By Wound Type

9.1. Negative Pressure Wound Therapy Market Revenue and Volume, by Wound Type, 2024-2033

9.1.1. Chronic Wounds

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Acute Wounds

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. Global Negative Pressure Wound Therapy Market, By End-use Type 

10.1. Negative Pressure Wound Therapy Market Revenue and Volume, by End-use Type, 2024-2033

10.1.1. Hospital

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Specialty Clinics

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Home Healthcare

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. Global Negative Pressure Wound Therapy Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.1.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.1.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.1.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.1.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.2.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.2.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.2.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.6.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.2.6.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.2.7.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.2.7.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.3.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.3.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.3.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.6.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.3.6.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.3.7.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.3.7.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.4.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.4.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.6.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.4.6.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.4.7.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.4.7.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.5.4.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.5.4.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

11.5.5.2. Market Revenue and Volume Forecast, by Wound Type (2021-2033)

11.5.5.3. Market Revenue and Volume Forecast, by End-use Type (2021-2033)

Chapter 12. Company Profiles

12.1. Acelity

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Conva Tec Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Cardinal Health

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cork Medical

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. DeRoyal Industries, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Genadyne Biotechnologies Inc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Invacare Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. 3M

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Molnlycke Health Care

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Paul Hartmann AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client